Skip to content

Clinical Efficacy of Acupoint Injection in the Treatment of Type 2 Diabetes Related Sarcopenia

Randomized controlled trial to evaluate the clinical efficacy of acupoint injection of Chinese medicine in patients with type 2 diabetes related sarcopenia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000839
Enrollment
Unknown
Registered
2025-04-24
Start date
2024-09-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes related sarcopenia

Interventions

Group A:acupoint injection+resistance training
Group B:resistance training

Sponsors

Shijiazhuang TCM Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) The diagnostic criteria for both type 2 diabetes and sarcopenia were met (2) Aged between 60 and 75 (3) Sign informed consent

Exclusion criteria

Exclusion criteria: 1) Patients with rheumatoid arthritis thyroid gland bone tumor pituitary gland parathyroid gland adrenal gland gonadal gland and other diseases affecting bone metabolism and fracture; 2) Within half a year use drugs that affect bone metabolism such as high-dose calcium estrogen androgen bisphosphonate glucocorticoid etc.; 3) Patients who have taken or injected vitamin D preparations within six months; 4) long-term bedridden hemiplegia 5) Have a clear history of infection 2 weeks before examination; (6) Patients with other serious cardiovascular and cerebrovascular diseases blood system endocrine system and liver and kidney diseases; 7) Patients with mental disorders; 8 Patients who could not complete the treatment according to the requirements of this study who could not judge the treatment effect and whose data was incomplete; 9) known allergy to the experimental drug; 10) History of smoking and heavy drinking;

Design outcomes

Primary

MeasureTime frame
Muscle function;Skeletal muscle index;Muscle strength;Bone metabolism index;

Countries

China

Contacts

Public ContactXIE Qiufang

Shijiazhuang TCM Hospital

503072112@qq.com18232103065

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026